SSI Diagnostica Group, a global leader in infectious disease clinical diagnostics, was originally established as a division of the prestigious Danish National Reference Center – Statens Serum Institut. Currently held by Adelis Equity, the SSI Diagnostica Group has grown significantly and now has its headquarters in Hillerød, Denmark. The company employs over 600 people across the globe and offers innovative solutions for disease surveillance, diagnosis, outbreak investigation, and quality control in three key areas: gastric, respiratory, and bloodborne diseases.

With administrative and manufacturing facilities located in Denmark, the United States, and China, and a strong global network of distribution partners, the SSI Diagnostica Group continues to build its position as a leading supplier of reagents and in vitro diagnostic (IVD) products worldwide.